Is REGN stock a buy?
What Is The Conclusion?
Right now our advanced algorithms say:
Do the analyst corps agree?
Interesting Questions and Easy Answers!
We cannot find any recorded dividends paid in our systems.
Sorry, we do not have any analyst data for this ticker
On Friday 21st of November 2014, Regeneron Pharmaceuticals had a stock price of $405.25. If you invested back then, your return now would be a profit of $338.10 per share or 83.43%
Yes, the average daily trading liquidity for Regeneron Pharmaceuticals is $608.72 million. You should therefore be able to get in and out of your positions relatively fast.
Regeneron Pharmaceuticals has little of the business financed by loans. This puts the company at lower risk in periods of high inflation where borrowing costs usually go up. With a high cash flow to debt ratio of 2.14, the company's ability to pay off the debt is good. Regeneron Pharmaceuticals has a very good net profit margin of 33.61% and should have very high tolerances against inflation.
We have calculated the inflation risk for Regeneron Pharmaceuticals to be low [0 out of 1]